{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:18:03Z","timestamp":1794356283208,"version":"4.9.0"},"reference-count":32,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Lipid-lowering drugs (LLDs) have protective effects against coronary artery disease (CAD) and cerebrovascular disease (CVD); however, a paradoxical association with cholesterol has been identified in several diseases, such as diabetes, dementia, and atrial fibrillation. We aimed to analyze the association between LLDs and cholesterol levels in older adults with type 2 diabetes mellitus (T2DM). This cross-sectional study enrolled consecutive patients aged \u226550 years from three centers in Taiwan. A multiple logistic regression model was used, and odds ratios (ORs) for different levels of total cholesterol (TC) or low-density-lipoprotein cholesterol (LDL-C) compared with the highest level were adjusted for age, triglyceride level, sex, comorbidities, and medications. Among the 3688 participants, 572 with and 676 without T2DM used LLDs. After adjusting for age and sex, the non-T2DM group demonstrated better medical conditions, cognition, and daily function than the T2DM group, regardless of LLD use. Compared to the highest TC level (\u2265240 mg\/dL), ORs were significantly increased as TC levels decreased. A similar pattern of T2DM prevalence was observed in LDL-C levels. Older people with T2DM demonstrated low cognitive and daily functions. Significantly reduced TC and LDL levels were associated with a higher T2DM prevalence in older adults regardless of LLD use. T2DM was associated with impaired cognitive and daily functioning. A higher prevalence of T2DM in older people with low cholesterol levels raises doubt surrounding cognition and daily function being jeopardized when the \u201clower is better\u201d strategy is applied for the secondary prevention of CAD or CVD.<\/jats:p>","DOI":"10.3390\/nu15143270","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T01:27:32Z","timestamp":1690248452000},"page":"3270","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cholesterol Paradox in Older People with Type 2 Diabetes Mellitus Regardless of Lipid-Lowering Drug Use: A Cross-Sectional Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"given":"Tzu-Yuan","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lun","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Show Chwan Memorial Hospital, Changhua 500, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-9877","authenticated-orcid":false,"given":"Cheng-Yu","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University, Taipei 111, Taiwan"},{"name":"Department of Neurology, Chang Bing Show Chwan Memorial Hospital, Changhua 505, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hsiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Department of Neurology, China Medical University Hospital, Taichung 404, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray-Chang","family":"Tzeng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2552-4516","authenticated-orcid":false,"given":"Pai-Yi","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Show Chwan Memorial Hospital, Changhua 500, Taiwan"},{"name":"Department of Applied Mathematics, Tunghai University, Taichung 407, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1021\/ar500260t","article-title":"The structural role of cholesterol in cell membranes: From condensed bilayers to lipid rafts","volume":"47","author":"Krause","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1743-7075-7-47","article-title":"Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones","volume":"7","author":"Hu","year":"2010","journal-title":"Nutr. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/qjmed\/hcg150","article-title":"High cholesterol may protect against infections and atherosclerosis","volume":"96","author":"Ravnskov","year":"2003","journal-title":"QJM"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0025-6196(11)60544-2","article-title":"Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease","volume":"84","author":"Karalis","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.107.720300","article-title":"Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention","volume":"117","author":"Grundy","year":"2008","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pcad.2020.12.008","article-title":"How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors","volume":"67","author":"Cybulska","year":"2021","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Burger, A.L., Pogran, E., Muthspiel, M., Kaufmann, C.C., Jager, B., and Huber, K. (2022). New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10050970"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2012.07.007","article-title":"The controversies of statin therapy: Weighing the evidence","volume":"60","author":"Jukema","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.amjcard.2012.12.037","article-title":"Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus","volume":"111","author":"Navarese","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc13-2215","article-title":"Statins and the risk of diabetes: Evidence from a large population-based cohort study","volume":"37","author":"Corrao","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11886-013-0461-4","article-title":"Statin treatment, new-onset diabetes, and other adverse effects: A systematic review","volume":"16","author":"Bang","year":"2014","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.amjcard.2014.08.041","article-title":"Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg\/dL) with rosuvastatin 20 mg daily (from JUPITER)","volume":"114","author":"Everett","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12944-019-1105-5","article-title":"U-shaped association between low-density lipid cholesterol and diabetes mellitus in patients with hypertension","volume":"18","author":"Liu","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0036933016681913","article-title":"Statins and the cholesterol mortality paradox","volume":"62","author":"Nunes","year":"2017","journal-title":"Scott. Med. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e012771","DOI":"10.1161\/JAHA.119.012771","article-title":"Low Lipid Levels and High Variability are Associated With the Risk of New-Onset Atrial Fibrillation","volume":"8","author":"Lee","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000006942","article-title":"Cholesterol paradox in patients with paroxysmal atrial fibrillation","volume":"92","author":"Annoura","year":"1999","journal-title":"Cardiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1253\/circj.CJ-11-1134","article-title":"\u201cCholesterol paradox\u201d in atrial fibrillation","volume":"75","author":"Suzuki","year":"2011","journal-title":"Circ. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/CIRCEP.113.001378","article-title":"Paradoxical association of lipoprotein measures with incident atrial fibrillation","volume":"7","author":"Mora","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"ehaa946.0451","DOI":"10.1093\/ehjci\/ehaa946.0451","article-title":"The cholesterol paradox in atrial fibrillation: Results from the LIPIDOGRAM 2015 study","volume":"41","author":"Harrison","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"(1998). Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation, 97, 1440\u20131445.","DOI":"10.1161\/01.CIR.97.15.1440"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2020.7848","article-title":"Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older","volume":"324","author":"Orkaby","year":"2020","journal-title":"JAMA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: Self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11863","DOI":"10.1038\/s41598-017-11070-x","article-title":"Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat beta-Cells. Direct Effect of Oxidative Stress","volume":"7","author":"Urbano","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia, U., Jebari, S., Larrea-Sebal, A., Uribe, K.B., Siddiqi, H., Ostolaza, H., Benito-Vicente, A., and Martin, C. (2020). Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134725"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1002\/jcp.28123","article-title":"Mechanisms of statin-induced new-onset diabetes","volume":"234","author":"Paseban","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurheartj\/ehy357","article-title":"PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: The role of the low-density lipoprotein receptor","volume":"40","author":"Ruscica","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41598-018-38461-y","article-title":"Total cholesterol and all-cause mortality by sex and age: A prospective cohort study among 12.8 million adults","volume":"9","author":"Yi","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/14\/3270\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:18:00Z","timestamp":1760127480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/14\/3270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":32,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["nu15143270"],"URL":"https:\/\/doi.org\/10.3390\/nu15143270","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]}}}